Lowering inflammation level by lp-pla2 inhibitor (darapladib) in early atherosclerosis development: In vivo rat type 2 diabetes mellitus model

Heriansyah Teuku, Wihastuti Titin Andri, Bambang Budi Siswanto, Anwar Santoso, Renan Sukmawan, Djanggan Sargowo, Imam Subekti, Am Aulanni, Nuryati Chairani Siregar, Saptawati Bordosono

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Lowering inflammation level by lp-pla2 inhibitor (darapladib) in early atherosclerosis development: In vivo rat type 2 diabetes mellitus model'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science